We are live on
!
Find out more
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
43 hedge funds and large institutions have $40M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
19% more capital invested
Capital invested by funds: $33.7M → $40M (+$6.27M)
13% more funds holding
Funds holding: 38 → 43 (+5)
10% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 10
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
43
Holders Change
+5
Holders Change %
+13.16%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
8
Increased
9
Reduced
10
Closed
3
Calls
$34K
Puts
–
Net Calls
+$34K
Net Calls Change
+$2K
Top Buyers
| 1 |
BlackRock
New York
|
+$188K |
| 2 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$32K |
| 3 |
Millennium Management
New York
|
+$25.4K |
| 4 |
HF
HRT Financial
New York
|
+$20.8K |
| 5 |
Renaissance Technologies
New York
|
+$18.7K |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.5M |
| 2 |
Creative Planning
Overland Park,
Kansas
|
-$39.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$27K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$16.8K |
